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The Relation Between the Incidence Rate of Second 
and Third Trimester Hemoglobin and the Incidence of 
Preeclampsia and Gestational Diabetes: A Cohort Study 
Introduction
Healthy pregnancy in terms of physical health and 
favorable mental health for the mother, infant, and 
family is the purpose of pregnancy-related cares (1). 
Prevalence of gestational diabetes is 2%-5% in the world 
with an approximate 40% increase during 1989-2002 
(2). Gestational diabetes and preeclampsia are among 
the major causes of perinatal morbidity, mortality, and 
preterm birth. In addition, diabetes is the most common 
endocrine disorder in pregnancy and responsible for a 
large group of perinatal complications such as fetal death, 
large for gestational age, damage during childbirth, and 
neonatal hypoglycemia (1). The level of blood factors 
like hemoglobin and hematocrit is a possible risk factor 
and thus a high level of hemoglobin can increase the 
incidence of preeclampsia and gestational diabetes in 
the afflicted women compared to those with a normal 
hemoglobin level (3). Since iron supplements are 
prescribed as a routine practice for pregnant women 
from the 20th week of pregnancy, it seems that in women 
with high hemoglobin levels, this may cause increased 
blood viscosity and consequent complications including 
preterm birth, low birth weight (LBW), preeclampsia, and 
gestational diabetes (4-6). High maternal hemoglobin level 
is considered as a test for early diagnosis of preeclampsia 
and gestational diabetes (6).
Gestational diabetes is a type of diabetes which first 
develops during the pregnancy by varying degrees of 
intolerance to carbohydrates (3). Prevalence of this type 
of diabetes is 2%-5% in the world. Larijani et al reported 
its prevalence as 4.5% in Tehran (7). Recent studies have 
indicated that the prevalence of gestational diabetes is 
increasing in all racial groups. Further, the World Health 
Organization (WHO) estimates that the incidence of 
diabetes in 2025 is 1.5 times more than its prevalence in 
2000. Furthermore, since the trend of gestational diabetes 
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prevalence follows the prevalence of type 2 diabetes, it 
is expected that the incidence of this disease to have an 
upward trend (8). Changes in insulin sensitivity develop 
during the first trimester as the fetus grows and thus 
insulin secretion increases due to insulin resistance. 
Accordingly, this state of resistance which is dependent on 
hormonal changes reaches its highest point. Physiological 
changes during the pregnancy can trigger gestational 
diabetes in susceptible people. Therefore, pregnancy is 
a diabetes-inducing condition and gestational diabetes 
is the most common metabolic disorder in this period 
(9). Moreover, gestational diabetes is accompanied by 
increased complications and unfavorable outcomes during 
the pregnancy and may cause long-term complications for 
the mother and infant (1).
Preeclampsia is one of the most prevalent problems of 
pregnancy and after hemorrhage and infection, is the third 
cause of maternal mortality. Additionally, it is regarded 
as one the most important causes of preterm childbirth, 
fetal growth restriction, and mortality during pregnancy. 
Preeclampsia is recognized by WHO as a global women 
health problem the cause of which is still unknown (10). 
Preeclampsia is an exclusively human disorder which is 
due to the advanced vascular disorders in women. Its 
prevalence is 5%-7% in the world and 20% in developing 
countries (2). As the most important pregnancy 
complication, preeclampsia leads to 15% of maternal 
mortalities and causes preterm birth and emergency 
cesarean section. In addition, it was considered the 
second cause of maternal mortality in Iran during 1997-
2000. Since the hemoglobin level is only used to diagnose 
maternal anemia in Iran, this study sought to determine 
the relationship between the second and third trimester 
hemoglobin levels and the incidence rate of preeclampsia, 
as well as gestational diabetes in pregnant women who 
referred to Milad hospital (Tehran) during 2011.
Materials and Methods
Study Type and Participants
This analytical research was conducted as a prospective 
cohort study. Research population included 600 pregnant 
women in the second and third trimesters who referred 
to perinatal clinic and delivery block of Milad hospital 
to receive perinatal, delivery, and post-delivery services 
during 2011. The minimum sample size was determined 
533 women based on the following formula and the 
confidence level of 95%, 25% (i.e., 25% relative error in the 
estimates), and prevalence of LBW (10%) and considering 
a 10% attrition rate, the final sample size included 600 
patients.
Totally, 700 pregnant women were selected and written 
consent was obtained from the women in the second 
and third trimesters who met the inclusion criteria and 
were interested to participate in the study. A form of 
demographic information and obstetric history was 
administered by an interview. Data regarding the patients’ 
weight and height were measured by a standard scale 
and a tape measure was attached to the scale. They were 
barefoot and with minimum clothes. Second and third 
trimester body mass indexes (BMIs) were calculated and 
blood pressure (BP) was recorded. Further, the levels of 
the second and third trimester hemoglobin were then 
obtained from the test results and recorded in the data 
form. Based on the hemoglobin levels, participants were 
divided into low, normal, and high hemoglobin groups. 
BP and unpredicted problems which might occur for the 
pregnant women were recorded in the information form. 
Finally, the type of delivery, gestational age, and infant 
weight were assessed in the delivery block and recorded 
in the form.
Inclusion criteria were singleton pregnancy, 18-35 years 
old, 13-26 week gestational age based on the first day of 
the last regular and reliable menstrual cycle or a second 
trimester ultrasound, three or less pregnancies, performing 
routine tests, receiving pregnancy and delivery care in 
Milad hospital, lack of any known underlying diseases 
including chronic BP, cardiovascular diseases, chronic 
renal, hematologic, thyroid, diabetic, gastrointestinal 
and neurological (epilepsy) diseases, thalassemia, and 
no history of unfavorable pregnancy outcomes (i.e., 
preeclampsia, gestational diabetes, preterm birth, LBW, 
fetal growth restriction, and stillbirth). Furthermore, the 
exclusion criteria encompassed known fetal anomaly, the 
incidence of polyhydramnios, oligohydramnios, placenta 
previa, placental abruption, abortion and fetal death in the 
current pregnancy, smoking, as well as the use of alcohol 
and other unusual medications during the pregnancy.
Data were collected in 11 months during March 2011- 
February 2012 and analyzed using the SPSS software, 
version 18. A 95% CI and a 0.05 maximum accepted error 
were employed. In line with the research goals, descriptive 
statistics including calculation of statistical indices, 
absolute and relative frequency distribution tables, mean 
and standard deviation were applied. Moreover, inferential 
statistics including chi-square, Fisher exact, one-way 
ANOVA, and Kolmogorov-Smirnov two-sample tests 
were utilized to compare the incidence rates of preterm 
birth and LBW.
Results
The results indicated that 70.5%-75.6% (second trimester-
third trimester) of the patients in the low hemoglobin 
group, 69.6%-73.0% of them in the normal hemoglobin 
group, and 66.8%-69.5% in the high hemoglobin group 
had middle-school education. Based on the results of the 
Kruskal-Wallis test, there was no statistically significant 
difference between education and the three groups in the 
second (P = 0.92) and third (P = 0.27) trimesters (Table 
1). Additionally, the participants’ husbands in all three 
groups had middle-school education and no significant 
difference was found between their education and their 
women’s hemoglobin level in the second (P = 0.41) and 
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third (P = 0.92) trimesters. As regards employment, 
the majority of the participants in all the groups were 
housewives and no significant difference was observed 
between employment and the three hemoglobin groups in 
the second (P = 0.26) and third (P = 0.52) trimesters. In 
addition, the majority of husbands were self-employed and 
there was no meaningful difference between employment 
and the 3 hemoglobin groups in the second (P = 0.08) and 
third (P = 0.84) trimesters. Further, results represented 
no significant difference between the second (P = 0.23) 
and third (P = 0.16) trimester hemoglobin levels and the 
number of pregnancies.
Based on the results, 85.6% (second trimester) and 
86.0% (third trimester) of the participants had no history 
of abortion and no significant relationship was detected 
between abortion and hemoglobin level. Furthermore, 
there was no significant association between hemoglobin 
level and duration of taking folic acid, iron pills, calcium, 
and multivitamin pills (folic acid: second trimester: P = 
0.63, third trimester: P = 0.15; iron pills: second trimester: 
P = 0.34, third trimester: P = 0.05; calcium: second 
trimester: P = 0.89, third trimester: P = 0.28; multivitamin 
pills: second trimester: P = 0.57, third trimester: P = 0.22).
A number of 47 (8.6% of the whole sample) women out 
of 600 women under investigation in the second trimester 
developed gestational diabetes of whom 22 (14.3%) 
patients were in the high hemoglobin group (≥12.5, P = 
0.01). The relative probability of developing gestational 
diabetes in the high hemoglobin group was 2.12 times 
greater compared to the normal hemoglobin group (CI = 
1.14-3.94). Moreover, such a risk was 0.33 times greater 
in the low hemoglobin group compared to the normal 
hemoglobin group (CI = 0.07-1.4). Forty-nine (8.2% of 
the whole sample) of the women under study in the third 
trimester were afflicted with gestational diabetes of whom 
31 (9.6%) were in the high hemoglobin group (≥12.5, 
P = 0.01). Additionally, the relative risk for developing 
gestational diabetes in the high hemoglobin group was 
1.47 times greater than that of the normal hemoglobin 
group (CI = 0.78-2.7) and it was 0.71 times greater in 
the low hemoglobin group compared to the normal 
hemoglobin group (CI = 0.16-3.2).
As regards preeclampsia, 39 (7.1% of the whole sample) 
women in the second trimester suffered from it, of 
whom 18 (11.7%) were in the high hemoglobin group 
(≥12.5). In addition, the relative probability of developing 
preeclampsia was 2.33 times greater in the high 
hemoglobin group compared to the normal hemoglobin 
group (CI = 1.16-4.66) and it was 0.95 times greater in 
the low hemoglobin group compared to the normal 
hemoglobin group (CI = 0.31-2.9).
Similarly, 40 (6.7% of the whole sample) women in the 
third trimester were afflicted with preeclampsia of whom 
23 (7.1%) were in the high hemoglobin group (≥12.5). 
The relative risk for developing preeclampsia in the high 
hemoglobin group was 1.33 times greater than that of the 
Table 1. The Average Age and BMI in Different Hemoglobin Groups
Hemoglobin (g/100 mL)
P Value
<11 11-12.4 ≥12.5   
Average age
2nd trimester 27.5±3.97 87.3±42.27 27.07±3.95 0.61
3rd trimester 27.1±3.44 27.47±4.14 27.16±3.84 0.64
1st trimester BMI 2nd trimester 24.75±4.63 24.84±4.29 25.41±4.48 0.36
3rd trimester BMI
2nd trimester 29.41±4.31 29.75±4.17 30.19±4.09 0.37
3rd trimester 29.64±5.01 29.92±4.14 27.77±4.05 0.87
Table 2. Absolute and Relative Frequency Distribution of Pregnant Women Referring to Milad Hospital of Tehran During the 2nd and 3rd 
Trimesters With Gestational Diabetes and Preeclampsia
Hemoglobin (g/100 mL)
Total
<11 11-12.4 ≥ 12.5
Developing gestational 
diabetes (2nd trimester 
hemoglobin)
Yes: No. (%) 76 ( 4.97 ) 293 ( 7.92 ) 132 ( 7.85 ) 501 ( 4.91 )
No: No. (%) 2 ( 6.2) 23 ( 3.7 ) 22 ( 3.14 ) 47 (6.8 )
RR (95% CI) 0.33 (0.07-4.1) 1 12.2 (14.1-94.3)
Developing gestational 
diabetes (3rd trimester 
hemoglobin)
Yes: No. (%) 39 ( 1.95 ) 221 ( 2.93 ) 291 ( 4.90 ) 551 (8.91 )
No: No. (%) 2 ( 9.4) 16 ( 8.6 ) 31 ( 6.9 ) 49 ( 2.8 )
RR (95% CI) 0.71 (0.16-2.3) 1 47.1 (0.78-7.2)
Developing 
preeclampsia (2nd 
trimester hemoglobin)
Yes: No. (%) 74 ( 9.94 ) 299 ( 6.94 ) 136 ( 3.88 ) 509 (9.92 )
No: No. (%) 4 ( 1.5 ) 17 (4.5 ) 18 ( 7.11 ) 39 ( 1.7 )
RR (95% CI) 0.95 (0.31-9.2) 1 33.2 (16.1-66.4)
Developing 
preeclampsia (3rd 
trimester hemoglobin)
Yes: No. (%) 37 ( 2.90 ) 224 ( 5.94 ) 299 ( 9.92 ) 560 ( 3.93 )
No: No. (%) 4 (8.9 ) 13 ( 5.5 ) 23 ( 1.7 ) 40 (7.6 )
RR (95% CI) 86.1 (0.58-1.6) 1 33.1 (0.66-66.2)
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normal hemoglobin group (CI = 0.66-2.66) and in the low 
hemoglobin group, it was 1.86 times greater compared to 
the normal hemoglobin group (CI = 0.58-6.1) (Table 2).
As illustrated in Figure 1, 12.55 g/100 mL of the 
hemoglobin in the third trimester and 11.85 g/100 mL in 
the second trimester are regarded as proper cut-off points 
for diagnosing gestational diabetes (Table 3).
Discussion and Conclusions
Various factors are involved in the incidence of unfavorable 
pregnancy outcomes which are referred to as the risk 
factors. One of the possible risk factors which has received 
attention is the level of blood factors like hemoglobin 
and hematocrit. Research on this field is limited and 
findings are contradictory (3-6). Determining the level 
of hemoglobin and hematocrit is currently a routine test 
in pregnancy. Further, anemia is diagnosed with low 
hemoglobin count and iron supplement treatment is 
prescribed accordingly. Furthermore, since it is a routine 
practice for all the pregnant women from the 20th week of 
pregnancy, it seems that this may cause increased blood 
viscosity and consequent complications in individuals 
with high hemoglobin levels (4, 6). Therefore, this study 
attempted to examine the relationship between the second 
and third trimester hemoglobin levels and the incidence 
of preeclampsia and gestational diabetes.
The normal plasma hemoglobin level is 2 ± 13 g/dL 
during non-pregnancy times and 2 ± 12 g/dL during 
pregnancy. Hemoglobin level slightly decreases in 
pregnancy due to a rise in blood volume (9). First and 
third trimester hemoglobin <11 g/dL and second trimester 
hemoglobin <10.5 g/dL are considered pregnancy 
anemia (9). Findings of Amburgey et al demonstrated 
that pre-pregnancy hemoglobin concentration increased 
significantly in women with preeclampsia and that there 
was a reverse relationship between maternal hemoglobin 
concentration and birth weight (11). Therefore, given 
the high prevalence of preeclampsia in women with 
first pregnancy and its maternal, fetal, and neonatal 
complications, prevention of the preeclampsia as an 
important health priority is a necessity for reducing 
maternal mortality and improving pregnancy final 
outcome (12). However, preventing preeclampsia is only 
possible when it is treated at early stages and before 
irreversible changes. Accordingly, early and appropriate 
diagnostic tests are required for successful treatment. 
An increase of 45% in plasma volume during pregnancy 
and an increase of 18%-33% in red cell mass reduces 
hemoglobin and hematocrit concentrations, especially in 
the second trimester. Failure in plasma volume increase 
leads to higher blood viscosity or increased hemoglobin 
and hematocrit levels (9). Normal hemodynamic 
changes during pregnancy do not occur in women with 
preeclampsia due to the plasma volume increase in the 
second trimester. Considering vascular spasms and 
non-occurrence of pregnancy-related hypervolemia in 
women with preeclampsia, it is possible that hemoglobin 
and hematocrit levels increase in these patients. Several 
studies suggested hemoglobin and hematocrit level as an 
early diagnostic test for preeclampsia (13). Research on 
142 women with first pregnancy revealed that maternal 
hemoglobin concentration increased in women with 
preeclampsia (11). Findings of another study conducted 
on 874 pregnant women in Thailand indicated that 
62 women (7.1%) developed preeclampsia of whom 
49 had high hemoglobin level while 65 women (7.4%) 
developed gestational diabetes of whom 36 had high 
hemoglobin level (3). Moreover, based on the results of 
this study, preeclampsia (relative risk [RR] = 3.3, CI = 
95%) and gestational diabetes (RR = 3.3, CI = 95%) were 
significantly related to high hemoglobin level. Similarly, 
a study in Iran implemented on 266 pregnant women 
represented that an increased hematocrit level in the 
first and third trimesters had a statistically significant 
relationship with the incidence rate of preeclampsia (14). 
Figure 1. The ROC Curve of Second and Third Trimester Hemoglobin 
for Diagnosing  of Gestational diabetes in Pregnant Women Referring to 
Milad Hospital (Tehran).
Figure 2. The ROC Curve of Second and Third Trimester Hemoglobin 
for Diagnosing the preeclampsia in Pregnant Women Referring to Milad 
Hospital (Tehran).
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Researchers compared hemoglobin levels of 444 women 
with preeclampsia with those of 15 825 healthy pregnant 
women and found that hemoglobin level was significantly 
higher in women with preeclampsia (15). Researchers 
reported that hemoglobin and its products are toxic and 
can cause oxidative stress, hemolysis, vascular spasms, 
renal damage, and endothelia and ultimately lead to a 
higher incidence of preeclampsia (16). A study in Iran 
during 2010-2011 performed on 650 pregnant women in 
the first to third trimesters indicated that 7.2% of women 
had preeclampsia and that their hemoglobin levels were 
significantly higher than those of the normal women (P 
= 0.003). Additionally, it was found that the hemoglobin 
level in the first trimester was significantly higher and 
lower than the second and third trimesters, respectively. 
In addition, first, second, and third trimester hemoglobin 
was found to help predict the incidence of preeclampsia 
(17).
Anaka et al studied 564 women and found that patients 
with HbA1C < 5.2 developed no gestational diabetes while 
all the patients with HbA1C > 6.1 developed gestational 
diabetes (18). Further, Amylidi et al investigated 208 
patients and concluded that the risk of developing 
gestational diabetes increased in pregnant women with 
high first trimester HbA1C. Finally, they found that 
HbA1C level could help predict the potential prevalence 
of gestational diabetes (19).
The results of the current study demonstrated that the 
high maternal hemoglobin levels in the second and third 
trimester of pregnancy were associated with an increased 
risk of gestational diabetes and preeclampsia, which is in 
line with the results of Khoigani et al (14). Furthermore, 
Pakniat et al indicated that high levels of hemoglobin 
in the first trimester of pregnancy could be a predictive 
factor for the incidence of preeclampsia (20). Moreover, 
it was indicated that high levels of hemoglobin at the first 
trimester of pregnancy could be a risk for preeclampsia 
(21). According to Murphy et al, a high level of 
hemoglobin in the first and second trimester of pregnancy 
was associated with preeclampsia incidence rate (22). Tan 
et al indicated that the high maternal hemoglobin level 
at the first prenatal visit was independently predictive of 
gestational diabetes mellitus (GDM) among the Asian 
population (23). Additionally, it was demonstrated that 
the high maternal hemoglobin (>13 g/dL) at the initial 
prenatal visit was an independent risk factor for GDM in 
Chinese studies (24). The hemoglobin levels in the first 
and second half of pregnancy can predict preeclampsia 
and premature preterm rupture of the membranes (14). 
The results of the current study indicated that the higher 
hemoglobin of mothers in the second and third trimester 
of pregnancy increased the risk of GDM and preeclampsia. 
This is in conformity with the results of previous studies. 
In addition, Gangor et al demonstrated there was 
no significant difference between the level of maternal 
hemoglobin in the second trimester and the incidence of 
gestational diabetes (25). However, Lao et al found that 
high maternal hemoglobin in early pregnancy could be 
an independent risk factor for gestational diabetes (24). 
Thus, further studies are needed to accurately assess the 
effect of maternal hemoglobin on undesirable pregnancy 
outcomes. Therefore, the results of this study seem to be 
helpful in reducing the adverse effects of pregnancy with 
careful care of women with high hemoglobin levels.
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